Attending #ESMOGI25? We’re looking forward to seeing you at our symposium, “Metastatic Pancreatic Cancer: Towards A Change In Patient Care?”!.🗓️ Today at 12:45 - 1:45 pm (CEST).More information at our booth – N° 5.#GICancer #gastrointestinalcancers #oncology #gastroenterology

Attending #ESMOGI25? Don’t forget to join our 2 symposiums 👇.🗓️ Today at 12:45 - 1:45 pm & 6:15 - 7:15 pm (CEST) .Find out more information at our booth – N° 5. #GICancer #gastrointestinalcancers #oncology #gastroenterology #cancer @myESMO

📢 Attending #ESMOGI25? Join us to discover the latest advances in #gastrointestinal cancers and share our expertise in the field. We hope to see you at our booth #5. Learn more about Servier’s commitments 🔗 #GICancer #gastrointestinalcancers #oncology

🚀 The convergence of cloud computing, artificial intelligence, and medical innovation could reinvent the discovery and distribution of drug development to allow for more access. That’s why we’ve been collaborated with @googlecloud  for five years to using their technologies

🌟 Servier India Private Limited has launched its second oncology treatment. After 38 years of strong presence in cardiovascular and metabolic diseases in India and launching its first drug in oncology for pancreatic cancer, we have reached a new stage in our oncology ambitions.

#EVF is now over! It was great to share the latest vascular-health research and scientific innovations with our peers. Learn more about Servier’s commitments 👉 @EuVenousForum #EVFCongress #VenousDiseases #VascularHealth

Attending #EVF? We look forward to seeing you and sharing the latest research and scientific innovations in vascular health. We hope to see you at our booth #9. Learn more about Servier’s commitments 🔗 @EuVenousForum #EVFCongress #VenousDiseases #EVF

🧡💙 Servier: 70 years, enthusiasm for reinvention!.Servier is governed by a nonprofit foundation. Our unique governance model ensures our independence, while supporting long-term innovation, with 100% of our profits reinvested in the Group’s development. 👇 Discover the

💙 Heart failure affects over 64 million people worldwide and is the leading cause of hospitalization for those over 65. In June, we are launching the 💙 #EveryPillMatters 💊 campaign to ensure heart failure patients take their treatments as prescribed. Join us and 🗣️ share

While awareness campaigns on #hypertension are useful for public education, they also help collect valuable screening data. As emphasized by British cardiologist Professor Neil Poulter, these data provide a clearer picture of the prevalence and management of high #bloodpressure

#BIO2025 is now over! We were pleased to connect with other industry leaders, share our latest research, and explore new partnering opportunities. Learn more about Servier 🔗 #collaboration #HealthcareInnovation #WeAreServier #MovedByYou @IAmBiotech

🚀 We are pleased to collaborate with the GEG Tech team, a partnership aimed at driving innovation hand-in-hand in drug discovery and screening!.GEG Tech is hosted at the Spartners by Servier & @biolabs incubator, located within our R&D Institute at Paris-Saclay and operated by

🧡💙 Servier: 70 years, the energy to endeavour!.Founded to serve health, our Group aspires to make a meaningful social impact for patients and for a sustainable world. 👇 Discover the perspectives of Cécilia, Lucie, MatthieuL, and Stephen. Explore more inspiring testimonials

💡 The rapid evolution of digital technologies is transforming healthcare as we know it. At Servier, we are convinced that these innovations hold immense potential to enhance the experience and outcomes for both patients and healthcare professionals 🤝. From streamlining

Did you know? High adherence to #hypertension treatment can reduce the risk of stroke by nearly 50%, especially for fatal and hemorrhagic strokes. As highlighted by British cardiologist Professor Neil Poulter, nearly 50% of people with high #bloodpressure stop their treatment

🏆 We are thrilled to announce that we have been recognized for the first time as the #1 pharma company worldwide working with patient groups in the 2024 #PatientView #Cancer Edition ranking. Based on feedback from 550 patient organizations, this achievement highlights our

🧡💙 Servier: 70 years, desire of commitment!.At Servier, we are committed to therapeutic progress to serve patient needs. 👇 Discover the perspectives and experiences of Alexandra, Filena, Grace, Guy, Joseph, Leszja, Priyam, and Shamin. Find out more testimonials 🔗

🎉 Today, we officially inaugurated Spartners by Servier & @biolabs, a start-ups incubator at the heart of one of the world’s most dynamic innovation ecosystems. 🌍✨. Located within our R&D institute, Spartners by Servier & BioLabs is unique in France. 🇫🇷 Operated by BioLabs,

Are you attending #BIO2025? Let’s meet in Boston! 📍 We are looking forward to connecting with industry leaders, sharing our latest research, and exploring potential partnering opportunities. 🤝. Learn more about Servier 👉 #collaboration

As the world’s 5th largest cardiology group, we have been involved in cardiovascular diseases for 70 years. In June, we are launching the 💙 #EveryPillMatters 💊 campaign to ensure heart failure patients take their treatments as prescribed. Join us and 🗣️ share our Facebook and